Provided by Tiger Trade Technology Pte. Ltd.

Goldman Sachs Future Health Care Equity ETF

37.02
-0.2314-0.62%
Post-market: 36.99-0.0285-0.08%16:10 EDT
Volume:549
Turnover:20.33K
Market Cap:19.43M
PE:- -
High:37.03
Open:37.03
Low:36.99
Close:37.25
52wk High:38.66
52wk Low:31.32
Shares:525.00K
Float Shares:525.00K
Volume Ratio:0.77
T/O Rate:0.10%
Dividend:0.11
Dividend Rate:0.31%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

When Weight Loss Isn't the Goal of Taking a GLP-1

Dow Jones
·
Sep 18

Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300

Reuters
·
Sep 18

Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 18

PepsiCo Adds Johnson & Johnson CEO Joaquin Duato to Board, Names Him to Audit Committee

Reuters
·
Sep 18

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 18

Ultragenyx confirms FDA approval of Fayuvi

TIPRANKS
·
Sep 18

Longeveron Stock (LGVN) Plummets 56% on a Failed Clinical Trial

TIPRANKS
·
Sep 18

Moderna: Another Day, Another Big Stock Move. is the Cancer Vaccine Rally Back On?

Dow Jones
·
Sep 18

US Health Secretary Kennedy Jr. Adds Eight New Members to Key Health Committee

Reuters
·
Sep 17

Guardant Health on Track for Record High Close

Dow Jones
·
Sep 17

Goldman Sachs Adjusts Eli Lilly Price Target to $1,371 From $1,367, Maintains Buy Rating

MT Newswires Live
·
Sep 17

Hemab Therapeutics doses first patient in HMB-003 trial

TIPRANKS
·
Sep 17

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

TIPRANKS
·
Sep 17

Fennec presents results from STS-J01 clinical trial evaluating Pedmark

TIPRANKS
·
Sep 17

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

TIPRANKS
·
Sep 17

Guizhou Bailing Unit Gets China Regulator's Nod to Trial Tangning Tongluo Cream

MT Newswires Live
·
Sep 17

GenScript Biotech Hits Near 5-Year High on Eli Lilly Collaboration

Reuters
·
Sep 17

Mountain County Embraces a New Wave of Technological Innovation

Deep News
·
Sep 17

Longeveron’s laromestrocel did not meet primary endpoint in Phase 2b HLHS trial

TIPRANKS
·
Sep 17

These ETFs Could Thrive in a Market Overcome by Interest-Rate Worries

Dow Jones
·
Sep 17